what is glp 1 derived from GLP-1 for Weight Loss and Diabetes What is GLP-1 & Does

Lilly is racing to cement its leadership by developing new injectables and expanding into oralsthe pharmas next generation oral GLP-1 agonist orforglipron recently showed injectable-like effects in a Phase III trialbut faces a potential threat from investigational therapies that are dosed less frequently

Findings: RCTSTEP-HFpEF DM trial - Semaglutide vs Placebo in Obese Diabetics with HFpEF, NEJM (2024) [PubMed abstract] Design: Randomized, placebo-controlled trial (N=616 | length = 52 weeks) in obese type 2 diabetics (BMI 30) with HFpEF Treatment: Semaglutide titrated to 2.4 mg once weekly vs Placebo Primary outcome: Change from baseline in the Kansas City Cardiomyopathy Questionnaire clinical summary score (KCCQ-CSS

In some cases, healthcare providers may consider delaying dose escalation to ensure optimal tolerance and minimize potential side effects during the initial phase of treatment

Some patients may be able to obtain daily fiber goals from food alone, whereas others may need to supplement their nutritional intake